Stories > Biopharma Innovator GeNeuro Discloses Progress

Biopharma Innovator GeNeuro Discloses Progress

4DMT Presents Positive Interim Data

ACTICOR BIOTECH Delays Key Documents

ALS Treatment Withdrawal: FDA Concerns

ADvantage Therapeutics Appoints Professo...

AMX0035 for PSP: Phase 3 Trial Commences

ARMGO Pharma's Positive Trial Results